HomeNOVN • SWX
add
Novartis AG
Nakaraang pagsara
CHF 91.56
Sakop ng araw
CHF 92.04 - CHF 93.99
Sakop ng taon
CHF 83.63 - CHF 102.72
Market cap
205.76B CHF
Average na Volume
2.97M
P/E ratio
12.39
Dividend yield
3.52%
Primary exchange
SWX
Sa balita
MRK
0.68%
0.41%
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 13.17B | 8.93% |
Gastos sa pagpapatakbo | 5.52B | -24.45% |
Net na kita | 3.19B | 81.09% |
Net profit margin | 24.21 | 66.28% |
Kita sa bawat share | 2.06 | 18.39% |
EBITDA | 5.50B | 88.62% |
Aktuwal na % ng binabayarang buwis | 5.91% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 13.85B | 8.08% |
Kabuuang asset | 103.52B | -8.14% |
Kabuuang sagutin | 60.08B | -19.30% |
Kabuuang equity | 43.44B | — |
Natitirang share | 2.00B | — |
Presyo para makapag-book | 4.23 | — |
Return on assets | 10.97% | — |
Return on capital | 15.05% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 3.19B | 81.09% |
Cash mula sa mga operasyon | 6.29B | 16.88% |
Cash mula sa pag-invest | -374.00M | 83.09% |
Cash mula sa financing | -382.00M | 54.09% |
Net change in cash | 5.71B | 275.39% |
Malayang cash flow | 4.55B | -63.57% |
Tungkol
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes”.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Itinatag
Peb 29, 1996
Headquarters
Website
Mga Empleyado
76,057